Dongye He | Medical Genetics | Best Researcher Award

🌟Dr. Dongye He, Medical Genetics, Best Researcher Award🏆

  •  Doctorate at Affiliated Hospital of Jining Medical University, China

Dongye He is a research associate at the Medical Research Center at the Affiliated Hospital of Jining Medical University in Shandong Province, China. He specializes in investigating the molecular etiology and disease mechanisms underlying rare genetic diseases in the endocrine system. Dongye holds a degree from Dalian University of Technology and has made significant contributions to understanding various endocrine disorders through his research.

Author Metrics

Dongye He has published 17 documents and garnered 165 citations from 149 documents, indicating the impact of his research in the field. His h-index, which measures both the productivity and citation impact of the publications, is 8. These metrics demonstrate Dongye’s contribution to the scholarly literature on endocrine disorders.

Scopus Profile

ORCID Profile

Education

Dongye He pursued his education at Dalian University of Technology, where he gained expertise in his field of study. He completed his education from September 2012 to June 2018, preparing him for a career in medical research focusing on rare genetic diseases in the endocrine system.

Research Focus

Dongye He’s research focuses on investigating the molecular mechanisms underlying rare genetic diseases in the endocrine system. He is particularly interested in disorders such as growth hormone deficiency and idiopathic hypogonadotropic hypogonadism. His work aims to enhance understanding of these conditions and develop effective diagnostic and therapeutic strategies.

Professional Journey

Dongye He began his professional journey as a research associate at the Medical Research Center at the Affiliated Hospital of Jining Medical University in September 2018. Since then, he has been actively involved in conducting research, publishing papers, and contributing to advancements in the field of endocrinology.

Honors & Awards

Dongye He’s contributions to the field of endocrinology have likely been recognized through various forms of academic recognition, such as conference presentations, scholarships, or institutional awards.

Publications Noted & Contributions

Dongye He has contributed to numerous publications focusing on topics ranging from molecular diagnosis and therapeutic evaluations of endocrine disorders to the pharmacological properties of natural compounds. His research has shed light on the genetic basis of rare genetic diseases and explored potential treatment options for these conditions.

Identification and functional analysis of first heterozygous frameshift mutation in the GHRH gene in a Chinese boy with isolated growth hormone deficiency” was published in the journal Gene in May 2024. The DOI for this article is 10.1016/j.gene.2024.148283. The contributors to this article are Shuoshuo Wei, Mei Zhang, Yanying Li, Wanling Yang, Chuanpeng Zhang, Fupeng Liu, Shuxiong Chen, Bo Ban, and Dongye He.

Functional investigation of a novel ANKRD11 frameshift variant identified in a Chinese family with KBG syndrome” was published in the journal Heliyon in March 2024. The DOI for this article is 10.1016/j.heliyon.2024.e28082. The contributors to this article are Shuoshuo Wei, Yanying Li, Wanling Yang, Shuxiong Chen, Fupeng Liu, Mei Zhang, Bo Ban, and Dongye He.

Letrozole combined with rhGH treatment increases the adult height of short pubertal boys” was published in the Journal of Pediatric Endocrinology & Metabolism (JPEM) on November 30, 2023. The DOI for this article is 10.1515/jpem-2023-0459. The PMID for this article is 38018388. The contributors to this article are He M, Zhang Y, Zhao Q, He D, Li Y, Zhang M, and Ban B.

Clinical Manifestations, Genetic Variants and Therapeutic Evaluation in Sporadic Chinese Patients with Idiopathic Hypogonadotropic Hypogonadism” was published in the International Journal of General Medicine in September 2023. The DOI for this article is 10.2147/IJGM.S430904. The contributors to this article are Dongye He, Hailing Sun, Mei Zhang, Yanying Li, Fupeng Liu, Yanhong Zhang, Mingming He, and Bo Ban.

Serum triglyceride glucose index is a valuable predictor for visceral obesity in patients with type 2 diabetes: a cross-sectional study” was published in the journal Cardiovascular Diabetology on April 29, 2023. The DOI for this article is 10.1186/s12933-023-01834-3. The PMID for this article is 37120516. The contributors to this article are Yang Q, Xu H, Zhang H, Li Y, Chen S, He D, Yang G, Ban B, Zhang M, and Liu F.

Research Timeline

Dongye He’s research journey has spanned several years, beginning with his education at Dalian University of Technology from September 2012 to June 2018. He then transitioned into his role as a research associate at the Medical Research Center at the Affiliated Hospital of Jining Medical University in September 2018, where he continues to contribute to advancements in the field.

Collaborations and Projects

Dongye He likely collaborates with colleagues and researchers within his institution and possibly from other institutions as well. His projects involve multidisciplinary approaches to understanding the molecular mechanisms of endocrine disorders and developing innovative solutions for diagnosis and treatment. Collaborations and projects play a crucial role in advancing scientific knowledge and addressing complex research questions in the field of endocrinology.